ND2: 4-(1-methylcyclopropyl)oxy-~{N}-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]-6-(1-methylpyrazol-4-yl)pyrido[3,2-d]pyrimidin-2-amine
ND2 is a Ligand Of Interest in 6TIA designated by the Author
| Best-fitted instance in this entry |
| Other instances in this entry |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
| 6TIA_ND2_B_501 | 82% | 6% | 0.083 | 0.941 | 1.31 | 3.49 | 3 | 18 | 0 | 0 | 100% | 1 |
| 6TIA_ND2_A_501 | 62% | 9% | 0.113 | 0.904 | 1.24 | 3.03 | 2 | 16 | 2 | 0 | 100% | 1 |
| 6TIA_ND2_B_502 | 29% | 9% | 0.143 | 0.799 | 1.24 | 3.07 | 2 | 16 | 0 | 0 | 100% | 1 |
| 6TIA_ND2_A_502 | 10% | 8% | 0.177 | 0.684 | 1.2 | 3.24 | 2 | 14 | 0 | 0 | 100% | 1 |
| 6TIA_ND2_B_504 | 3% | 7% | 0.175 | 0.533 | 1.24 | 3.33 | 2 | 13 | 0 | 0 | 100% | 1 |
| 6TIA_ND2_A_504 | 3% | 8% | 0.194 | 0.545 | 1.25 | 3.15 | 2 | 14 | 0 | 0 | 100% | 1 |
| 6TIA_ND2_A_505 | 3% | 5% | 0.191 | 0.514 | 1.33 | 3.72 | 2 | 15 | 0 | 0 | 100% | 1 |
| 6TIA_ND2_B_503 | 2% | 5% | 0.181 | 0.479 | 1.38 | 3.61 | 4 | 16 | 2 | 0 | 100% | 1 |
| 6TIA_ND2_B_505 | 1% | 5% | 0.18 | 0.413 | 1.3 | 3.84 | 2 | 20 | 0 | 0 | 100% | 1 |
| 6TIA_ND2_A_503 | 1% | 6% | 0.19 | 0.396 | 1.32 | 3.54 | 2 | 14 | 0 | 0 | 100% | 1 |